[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global High Dose Radiation (HDR) Monotherapy Sales Market Report 2016

September 2016 | 126 pages | ID: GC119F94A17EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of High Dose Radiation (HDR) Monotherapy

Revenue, means the sales value of High Dose Radiation (HDR) Monotherapy

This report studies sales (consumption) of High Dose Radiation (HDR) Monotherapy in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Pfizer Inc. (USA)
  • Abbott Laboratories (USA)
  • Genentech Inc. (USA)
  • GlaxoSmithKline Plc (UK)
  • Immunomedics, Inc. (USA)
  • Indevus Pharmaceuticals Inc. (USA)
  • Novartis AG (Switzerland)
  • OSI Pharmaceuticals, Inc. (USA)
  • Paladin Labs Inc. (Canada)
  • ALZA Corporation (USA)
  • Amgen Inc. (USA)
  • AstraZeneca PLC (UK)
  • Medimmune, LLC (USA)
  • Bristol-Myers Squibb Company (USA)
  • Cell Genesys Inc. (USA)
  • Dendreon Corporation (USA)
  • EUSA Pharma, (USA) Inc. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Progenics Pharmaceuticals, Inc. (USA)
  • Sanofi-Aventis SA (France)
  • Spectrum Pharmaceuticals, Inc. (USA)
  • Takeda Pharmaceutical Company Limited (Japan)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of High Dose Radiation (HDR) Monotherapy in these regions, from 2011 to 2021 (forecast), like
  • USA
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of High Dose Radiation (HDR) Monotherapy in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global High Dose Radiation (HDR) Monotherapy Sales Market Report 2016

1 HIGH DOSE RADIATION (HDR) MONOTHERAPY OVERVIEW

1.1 Product Overview and Scope of High Dose Radiation (HDR) Monotherapy
1.2 Classification of High Dose Radiation (HDR) Monotherapy
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of High Dose Radiation (HDR) Monotherapy
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 High Dose Radiation (HDR) Monotherapy Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of High Dose Radiation (HDR) Monotherapy (2011-2021)
  1.5.1 Global High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2021)
  1.5.2 Global High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)

2 GLOBAL HIGH DOSE RADIATION (HDR) MONOTHERAPY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global High Dose Radiation (HDR) Monotherapy Market Competition by Manufacturers
  2.1.1 Global High Dose Radiation (HDR) Monotherapy Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global High Dose Radiation (HDR) Monotherapy Revenue and Share by Manufacturers (2011-2016)
2.2 Global High Dose Radiation (HDR) Monotherapy (Volume and Value) by Type
  2.2.1 Global High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type (2011-2016)
  2.2.2 Global High Dose Radiation (HDR) Monotherapy Revenue and Market Share by Type (2011-2016)
2.3 Global High Dose Radiation (HDR) Monotherapy (Volume and Value) by Regions
  2.3.1 Global High Dose Radiation (HDR) Monotherapy Sales and Market Share by Regions (2011-2016)
  2.3.2 Global High Dose Radiation (HDR) Monotherapy Revenue and Market Share by Regions (2011-2016)
2.4 Global High Dose Radiation (HDR) Monotherapy (Volume) by Application

3 USA HIGH DOSE RADIATION (HDR) MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

3.1 USA High Dose Radiation (HDR) Monotherapy Sales and Value (2011-2016)
  3.1.1 USA High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
  3.1.2 USA High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
  3.1.3 USA High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
3.2 USA High Dose Radiation (HDR) Monotherapy Sales and Market Share by Manufacturers
3.3 USA High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type
3.4 USA High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application

4 CHINA HIGH DOSE RADIATION (HDR) MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

4.1 China High Dose Radiation (HDR) Monotherapy Sales and Value (2011-2016)
  4.1.1 China High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
  4.1.2 China High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
  4.1.3 China High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
4.2 China High Dose Radiation (HDR) Monotherapy Sales and Market Share by Manufacturers
4.3 China High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type
4.4 China High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application

5 EUROPE HIGH DOSE RADIATION (HDR) MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

5.1 Europe High Dose Radiation (HDR) Monotherapy Sales and Value (2011-2016)
  5.1.1 Europe High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
  5.1.2 Europe High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
  5.1.3 Europe High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
5.2 Europe High Dose Radiation (HDR) Monotherapy Sales and Market Share by Manufacturers
5.3 Europe High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type
5.4 Europe High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application

6 JAPAN HIGH DOSE RADIATION (HDR) MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Japan High Dose Radiation (HDR) Monotherapy Sales and Value (2011-2016)
  6.1.1 Japan High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
  6.1.2 Japan High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
  6.1.3 Japan High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
6.2 Japan High Dose Radiation (HDR) Monotherapy Sales and Market Share by Manufacturers
6.3 Japan High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type
6.4 Japan High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application

7 INDIA HIGH DOSE RADIATION (HDR) MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 India High Dose Radiation (HDR) Monotherapy Sales and Value (2011-2016)
  7.1.1 India High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
  7.1.2 India High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
  7.1.3 India High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
7.2 India High Dose Radiation (HDR) Monotherapy Sales and Market Share by Manufacturers
7.3 India High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type
7.4 India High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application

8 SOUTHEAST ASIA HIGH DOSE RADIATION (HDR) MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia High Dose Radiation (HDR) Monotherapy Sales and Value (2011-2016)
  8.1.1 Southeast Asia High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
8.2 Southeast Asia High Dose Radiation (HDR) Monotherapy Sales and Market Share by Manufacturers
8.3 Southeast Asia High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type
8.4 Southeast Asia High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application

9 GLOBAL HIGH DOSE RADIATION (HDR) MONOTHERAPY MANUFACTURERS ANALYSIS

9.1 Pfizer Inc. (USA)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 High Dose Radiation (HDR) Monotherapy Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Pfizer Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories (USA)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 126 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Abbott Laboratories (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Genentech Inc. (USA)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 143 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Genentech Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline Plc (UK)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Aug Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 GlaxoSmithKline Plc (UK) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Immunomedics, Inc. (USA)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Immunomedics, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Indevus Pharmaceuticals Inc. (USA)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Indevus Pharmaceuticals Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Novartis AG (Switzerland)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharma & Healthcare Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Novartis AG (Switzerland) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 OSI Pharmaceuticals, Inc. (USA)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 OSI Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Paladin Labs Inc. (Canada)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Paladin Labs Inc. (Canada) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 ALZA Corporation (USA)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 ALZA Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Amgen Inc. (USA)
9.12 AstraZeneca PLC (UK)
9.13 Medimmune, LLC (USA)
9.14 Bristol-Myers Squibb Company (USA)
9.15 Cell Genesys Inc. (USA)
9.16 Dendreon Corporation (USA)
9.17 EUSA Pharma, (USA) Inc. (USA)
9.18 F. Hoffmann-La Roche Ltd. (Switzerland)
9.19 Progenics Pharmaceuticals, Inc. (USA)
9.20 Sanofi-Aventis SA (France)
9.21 Spectrum Pharmaceuticals, Inc. (USA)
9.22 Takeda Pharmaceutical Company Limited (Japan)

10 HIGH DOSE RADIATION (HDR) MONOTHERAPY MAUFACTURING COST ANALYSIS

10.1 High Dose Radiation (HDR) Monotherapy Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of High Dose Radiation (HDR) Monotherapy

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 High Dose Radiation (HDR) Monotherapy Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of High Dose Radiation (HDR) Monotherapy Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL HIGH DOSE RADIATION (HDR) MONOTHERAPY MARKET FORECAST (2016-2021)

14.1 Global High Dose Radiation (HDR) Monotherapy Sales, Revenue Forecast (2016-2021)
14.2 Global High Dose Radiation (HDR) Monotherapy Sales Forecast by Regions (2016-2021)
14.3 Global High Dose Radiation (HDR) Monotherapy Sales Forecast by Type (2016-2021)
14.4 Global High Dose Radiation (HDR) Monotherapy Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of High Dose Radiation (HDR) Monotherapy
Table Classification of High Dose Radiation (HDR) Monotherapy
Figure Global Sales Market Share of High Dose Radiation (HDR) Monotherapy by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of High Dose Radiation (HDR) Monotherapy
Figure Global Sales Market Share of High Dose Radiation (HDR) Monotherapy by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Figure China High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Figure Europe High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Figure Japan High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Figure India High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Figure Southeast Asia High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Figure Global High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2021)
Figure Global High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2021)
Table Global High Dose Radiation (HDR) Monotherapy Sales of Key Manufacturers (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Sales Share by Manufacturers (2011-2016)
Figure 2015 High Dose Radiation (HDR) Monotherapy Sales Share by Manufacturers
Figure 2016 High Dose Radiation (HDR) Monotherapy Sales Share by Manufacturers
Table Global High Dose Radiation (HDR) Monotherapy Revenue by Manufacturers (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Revenue Share by Manufacturers (2011-2016)
Table 2015 Global High Dose Radiation (HDR) Monotherapy Revenue Share by Manufacturers
Table 2016 Global High Dose Radiation (HDR) Monotherapy Revenue Share by Manufacturers
Table Global High Dose Radiation (HDR) Monotherapy Sales and Market Share by Type (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Sales Share by Type (2011-2016)
Figure Sales Market Share of High Dose Radiation (HDR) Monotherapy by Type (2011-2016)
Figure Global High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Type (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Revenue and Market Share by Type (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of High Dose Radiation (HDR) Monotherapy by Type (2011-2016)
Figure Global High Dose Radiation (HDR) Monotherapy Revenue Growth Rate by Type (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Sales and Market Share by Regions (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Sales Share by Regions (2011-2016)
Figure Sales Market Share of High Dose Radiation (HDR) Monotherapy by Regions (2011-2016)
Figure Global High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Regions (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Revenue and Market Share by Regions (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of High Dose Radiation (HDR) Monotherapy by Regions (2011-2016)
Figure Global High Dose Radiation (HDR) Monotherapy Revenue Growth Rate by Regions (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Sales and Market Share by Application (2011-2016)
Table Global High Dose Radiation (HDR) Monotherapy Sales Share by Application (2011-2016)
Figure Sales Market Share of High Dose Radiation (HDR) Monotherapy by Application (2011-2016)
Figure Global High Dose Radiation (HDR) Monotherapy Sales Growth Rate by Application (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
Figure USA High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales by Manufacturers (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Market Share by Manufacturers (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Market Share by Type (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table USA High Dose Radiation (HDR) Monotherapy Market Share by Application (2011-2016)
Figure China High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
Figure China High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
Figure China High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
Table China High Dose Radiation (HDR) Monotherapy Sales by Manufacturers (2011-2016)
Table China High Dose Radiation (HDR) Monotherapy Market Share by Manufacturers (2011-2016)
Table China High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table China High Dose Radiation (HDR) Monotherapy Market Share by Type (2011-2016)
Table China High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table China High Dose Radiation (HDR) Monotherapy Market Share by Application (2011-2016)
Figure Europe High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
Figure Europe High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
Figure Europe High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
Table Europe High Dose Radiation (HDR) Monotherapy Sales by Manufacturers (2011-2016)
Table Europe High Dose Radiation (HDR) Monotherapy Market Share by Manufacturers (2011-2016)
Table Europe High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table Europe High Dose Radiation (HDR) Monotherapy Market Share by Type (2011-2016)
Table Europe High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table Europe High Dose Radiation (HDR) Monotherapy Market Share by Application (2011-2016)
Figure Japan High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
Figure Japan High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
Figure Japan High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
Table Japan High Dose Radiation (HDR) Monotherapy Sales by Manufacturers (2011-2016)
Table Japan High Dose Radiation (HDR) Monotherapy Market Share by Manufacturers (2011-2016)
Table Japan High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table Japan High Dose Radiation (HDR) Monotherapy Market Share by Type (2011-2016)
Table Japan High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table Japan High Dose Radiation (HDR) Monotherapy Market Share by Application (2011-2016)
Figure India High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
Figure India High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
Figure India High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
Table India High Dose Radiation (HDR) Monotherapy Sales by Manufacturers (2011-2016)
Table India High Dose Radiation (HDR) Monotherapy Market Share by Manufacturers (2011-2016)
Table India High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table India High Dose Radiation (HDR) Monotherapy Market Share by Type (2011-2016)
Table India High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table India High Dose Radiation (HDR) Monotherapy Market Share by Application (2011-2016)
Figure Southeast Asia High Dose Radiation (HDR) Monotherapy Sales and Growth Rate (2011-2016)
Figure Southeast Asia High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate (2011-2016)
Figure Southeast Asia High Dose Radiation (HDR) Monotherapy Sales Price Trend (2011-2016)
Table Southeast Asia High Dose Radiation (HDR) Monotherapy Sales by Manufacturers (2011-2016)
Table Southeast Asia High Dose Radiation (HDR) Monotherapy Market Share by Manufacturers (2011-2016)
Table Southeast Asia High Dose Radiation (HDR) Monotherapy Sales by Type (2011-2016)
Table Southeast Asia High Dose Radiation (HDR) Monotherapy Market Share by Type (2011-2016)
Table Southeast Asia High Dose Radiation (HDR) Monotherapy Sales by Application (2011-2016)
Table Southeast Asia High Dose Radiation (HDR) Monotherapy Market Share by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca PLC (UK) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medimmune, LLC (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cell Genesys Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Corporation (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure EUSA Pharma, (USA) Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Progenics Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis SA (France) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Spectrum Pharmaceuticals, Inc. (USA) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) High Dose Radiation (HDR) Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited (Japan) High Dose Radiation (HDR) Monotherapy Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Dose Radiation (HDR) Monotherapy
Figure Manufacturing Process Analysis of High Dose Radiation (HDR) Monotherapy
Figure High Dose Radiation (HDR) Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of High Dose Radiation (HDR) Monotherapy Major Manufacturers in 2015
Table Major Buyers of High Dose Radiation (HDR) Monotherapy
Table Distributors/Traders List
Figure Global High Dose Radiation (HDR) Monotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Global High Dose Radiation (HDR) Monotherapy Revenue and Growth Rate Forecast (2016-2021)
Table Global High Dose Radiation (HDR) Monotherapy Sales Forecast by Regions (2016-2021)
Table Global High Dose Radiation (HDR) Monotherapy Sales Forecast by Type (2016-2021)
Table Global High Dose Radiation (HDR) Monotherapy Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories